Form 4: Nevro Corp. Executive Christofer Christoforou Reports Stock Transaction

SVP and Chief Operating Officer of Nevro Corp., Christofer Christoforou, disposed of 1,319 shares of common stock to cover tax obligations.

Summary

• Christofer Christoforou, the SVP and Chief Operating Officer of Nevro Corp., reported a transaction involving the company's stock.
• On December 7, 2024, Mr. Christoforou disposed of 1,319 shares of common stock.
• The shares were disposed of at a price of $4.19 per share.
• This transaction was to cover tax obligations related to the vesting of restricted stock units.
• Following the transaction, Mr. Christoforou beneficially owns 137,080 shares of Nevro Corp., which includes 106,473 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of an insider stock transaction. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical executive stock transactions.
• Similar filings are regularly made by executives at comparable medical device companies such as Medtronic, Boston Scientific, and Abbott, when they exercise options or sell shares.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive to cover tax obligations.

Key Dates

Keywords

Nevro Corp, stock transaction, insider trading, Form 4, Christofer Christoforou, restricted stock units, executive compensation